Inhibitory Gating Modulation of Small Conductance Ca super(2+)-Activated K super(+) Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons

SK channels are small conductance Ca super(2+)-activated K super(+) channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts ex...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 2006-11, Vol.70 (5), p.1771-1782
Hauptverfasser: Stroebaek, Dorte, Hougaard, Charlotte, Johansen, Tina H, Soerensen, Ulrik S, Nielsen, Elsebet Oe, Nielsen, Karin S, Taylor, Ruth DT, Pedarzani, Paola, Christophersen, Palle
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1782
container_issue 5
container_start_page 1771
container_title Molecular pharmacology
container_volume 70
creator Stroebaek, Dorte
Hougaard, Charlotte
Johansen, Tina H
Soerensen, Ulrik S
Nielsen, Elsebet Oe
Nielsen, Karin S
Taylor, Ruth DT
Pedarzani, Paola
Christophersen, Palle
description SK channels are small conductance Ca super(2+)-activated K super(+) channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts extracellularly by a pore-blocking mechanism. 1-Ethyl-2-benzimidazolinone (1-EBIO) and 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) have been identified as positive gating modulators that increase the apparent Ca super(2+) sensitivity of SK channels. In the present study, we describe inhibitory gating modulation as a novel principle for selective inhibition of SK channels. In wholecell patch-clamp experiments, the compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3) with potencies around 100 nM. However, in contrast to known pore blockers, NS8593 did not inhibit super(125)I-apamin binding. Using excised patches, it was demonstrated that NS8593 decreased the Ca super(2+) sensitivity by shifting the activation curve for Ca super(2+) to the right, only slightly affecting the maximal Ca super(2+)-activated SK current. NS8593 inhibited all the SK1-3 subtypes Ca super(2+)-dependently (K sub(d) = 0.42, 0.60, and 0.73 mu M, respectively, at 0.5 mu M Ca super(2+)), whereas the compound did not affect the Ca super(2+)-activated K super(+) channels of intermediate and large conductance (hIK and hBK channels, respectively). The site of action was accessible from both sides of the membrane, and the NS8593-mediated inhibition was prevented in the presence of a high concentration of the positive modulator NS309. NS8593 was further tested on mouse CA1 neurons in hippocampal slices and shown to inhibit the apaminand tubocurarine-sensitive SK-mediated afterhyperpolarizing current, at a concentration of 3 mu M.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_19359957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19359957</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_193599573</originalsourceid><addsrcrecordid>eNqNT8tKw0AUzULB-viHu5IEO5BHo82yBrUidtG6cFduk1szMrkzzkNIf92NEfoBrs7hcDiPk2iSpvmtmFfl-1l07txnmmazcp5Oop9n7uROem0HeEIv-QNedRvUSDWD3sOmR6Wg1tyGxiM3BDWCC4ZsnN8kYtF4-Y2eWng5qjcJ1B0yk3KwG8B3BJuBR_CyGXN6owO3EK8TsRLxPfFB9rLFg1YiF4NKRDbNp8V0Jjx5i93QWi0ywWg6PyjsJRPEq828rIoE1jSOIgeLvSfbDWO70QqtPPzdqIO1xB4kw1IaoxvsDY5PFhmsKFjN7jI63aNydHXEi-j68eGtXgpj9Vcg57e9dA0phUw6uG1WFWVVlXfFv42_Z_18HQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19359957</pqid></control><display><type>article</type><title>Inhibitory Gating Modulation of Small Conductance Ca super(2+)-Activated K super(+) Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Stroebaek, Dorte ; Hougaard, Charlotte ; Johansen, Tina H ; Soerensen, Ulrik S ; Nielsen, Elsebet Oe ; Nielsen, Karin S ; Taylor, Ruth DT ; Pedarzani, Paola ; Christophersen, Palle</creator><creatorcontrib>Stroebaek, Dorte ; Hougaard, Charlotte ; Johansen, Tina H ; Soerensen, Ulrik S ; Nielsen, Elsebet Oe ; Nielsen, Karin S ; Taylor, Ruth DT ; Pedarzani, Paola ; Christophersen, Palle</creatorcontrib><description>SK channels are small conductance Ca super(2+)-activated K super(+) channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts extracellularly by a pore-blocking mechanism. 1-Ethyl-2-benzimidazolinone (1-EBIO) and 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) have been identified as positive gating modulators that increase the apparent Ca super(2+) sensitivity of SK channels. In the present study, we describe inhibitory gating modulation as a novel principle for selective inhibition of SK channels. In wholecell patch-clamp experiments, the compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3) with potencies around 100 nM. However, in contrast to known pore blockers, NS8593 did not inhibit super(125)I-apamin binding. Using excised patches, it was demonstrated that NS8593 decreased the Ca super(2+) sensitivity by shifting the activation curve for Ca super(2+) to the right, only slightly affecting the maximal Ca super(2+)-activated SK current. NS8593 inhibited all the SK1-3 subtypes Ca super(2+)-dependently (K sub(d) = 0.42, 0.60, and 0.73 mu M, respectively, at 0.5 mu M Ca super(2+)), whereas the compound did not affect the Ca super(2+)-activated K super(+) channels of intermediate and large conductance (hIK and hBK channels, respectively). The site of action was accessible from both sides of the membrane, and the NS8593-mediated inhibition was prevented in the presence of a high concentration of the positive modulator NS309. NS8593 was further tested on mouse CA1 neurons in hippocampal slices and shown to inhibit the apaminand tubocurarine-sensitive SK-mediated afterhyperpolarizing current, at a concentration of 3 mu M.</description><identifier>ISSN: 0026-895X</identifier><language>eng</language><ispartof>Molecular pharmacology, 2006-11, Vol.70 (5), p.1771-1782</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Stroebaek, Dorte</creatorcontrib><creatorcontrib>Hougaard, Charlotte</creatorcontrib><creatorcontrib>Johansen, Tina H</creatorcontrib><creatorcontrib>Soerensen, Ulrik S</creatorcontrib><creatorcontrib>Nielsen, Elsebet Oe</creatorcontrib><creatorcontrib>Nielsen, Karin S</creatorcontrib><creatorcontrib>Taylor, Ruth DT</creatorcontrib><creatorcontrib>Pedarzani, Paola</creatorcontrib><creatorcontrib>Christophersen, Palle</creatorcontrib><title>Inhibitory Gating Modulation of Small Conductance Ca super(2+)-Activated K super(+) Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons</title><title>Molecular pharmacology</title><description>SK channels are small conductance Ca super(2+)-activated K super(+) channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts extracellularly by a pore-blocking mechanism. 1-Ethyl-2-benzimidazolinone (1-EBIO) and 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) have been identified as positive gating modulators that increase the apparent Ca super(2+) sensitivity of SK channels. In the present study, we describe inhibitory gating modulation as a novel principle for selective inhibition of SK channels. In wholecell patch-clamp experiments, the compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3) with potencies around 100 nM. However, in contrast to known pore blockers, NS8593 did not inhibit super(125)I-apamin binding. Using excised patches, it was demonstrated that NS8593 decreased the Ca super(2+) sensitivity by shifting the activation curve for Ca super(2+) to the right, only slightly affecting the maximal Ca super(2+)-activated SK current. NS8593 inhibited all the SK1-3 subtypes Ca super(2+)-dependently (K sub(d) = 0.42, 0.60, and 0.73 mu M, respectively, at 0.5 mu M Ca super(2+)), whereas the compound did not affect the Ca super(2+)-activated K super(+) channels of intermediate and large conductance (hIK and hBK channels, respectively). The site of action was accessible from both sides of the membrane, and the NS8593-mediated inhibition was prevented in the presence of a high concentration of the positive modulator NS309. NS8593 was further tested on mouse CA1 neurons in hippocampal slices and shown to inhibit the apaminand tubocurarine-sensitive SK-mediated afterhyperpolarizing current, at a concentration of 3 mu M.</description><issn>0026-895X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNT8tKw0AUzULB-viHu5IEO5BHo82yBrUidtG6cFduk1szMrkzzkNIf92NEfoBrs7hcDiPk2iSpvmtmFfl-1l07txnmmazcp5Oop9n7uROem0HeEIv-QNedRvUSDWD3sOmR6Wg1tyGxiM3BDWCC4ZsnN8kYtF4-Y2eWng5qjcJ1B0yk3KwG8B3BJuBR_CyGXN6owO3EK8TsRLxPfFB9rLFg1YiF4NKRDbNp8V0Jjx5i93QWi0ywWg6PyjsJRPEq828rIoE1jSOIgeLvSfbDWO70QqtPPzdqIO1xB4kw1IaoxvsDY5PFhmsKFjN7jI63aNydHXEi-j68eGtXgpj9Vcg57e9dA0phUw6uG1WFWVVlXfFv42_Z_18HQ</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Stroebaek, Dorte</creator><creator>Hougaard, Charlotte</creator><creator>Johansen, Tina H</creator><creator>Soerensen, Ulrik S</creator><creator>Nielsen, Elsebet Oe</creator><creator>Nielsen, Karin S</creator><creator>Taylor, Ruth DT</creator><creator>Pedarzani, Paola</creator><creator>Christophersen, Palle</creator><scope>7QP</scope><scope>7TK</scope></search><sort><creationdate>20061101</creationdate><title>Inhibitory Gating Modulation of Small Conductance Ca super(2+)-Activated K super(+) Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons</title><author>Stroebaek, Dorte ; Hougaard, Charlotte ; Johansen, Tina H ; Soerensen, Ulrik S ; Nielsen, Elsebet Oe ; Nielsen, Karin S ; Taylor, Ruth DT ; Pedarzani, Paola ; Christophersen, Palle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_193599573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stroebaek, Dorte</creatorcontrib><creatorcontrib>Hougaard, Charlotte</creatorcontrib><creatorcontrib>Johansen, Tina H</creatorcontrib><creatorcontrib>Soerensen, Ulrik S</creatorcontrib><creatorcontrib>Nielsen, Elsebet Oe</creatorcontrib><creatorcontrib>Nielsen, Karin S</creatorcontrib><creatorcontrib>Taylor, Ruth DT</creatorcontrib><creatorcontrib>Pedarzani, Paola</creatorcontrib><creatorcontrib>Christophersen, Palle</creatorcontrib><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stroebaek, Dorte</au><au>Hougaard, Charlotte</au><au>Johansen, Tina H</au><au>Soerensen, Ulrik S</au><au>Nielsen, Elsebet Oe</au><au>Nielsen, Karin S</au><au>Taylor, Ruth DT</au><au>Pedarzani, Paola</au><au>Christophersen, Palle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory Gating Modulation of Small Conductance Ca super(2+)-Activated K super(+) Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons</atitle><jtitle>Molecular pharmacology</jtitle><date>2006-11-01</date><risdate>2006</risdate><volume>70</volume><issue>5</issue><spage>1771</spage><epage>1782</epage><pages>1771-1782</pages><issn>0026-895X</issn><abstract>SK channels are small conductance Ca super(2+)-activated K super(+) channels important for the control of neuronal excitability, the fine tuning of firing patterns, and the regulation of synaptic mechanisms. The classic SK channel pharmacology has largely focused on the peptide apamin, which acts extracellularly by a pore-blocking mechanism. 1-Ethyl-2-benzimidazolinone (1-EBIO) and 6,7-dichloro-1H-indole-2,3-dione 3-oxime (NS309) have been identified as positive gating modulators that increase the apparent Ca super(2+) sensitivity of SK channels. In the present study, we describe inhibitory gating modulation as a novel principle for selective inhibition of SK channels. In wholecell patch-clamp experiments, the compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3) with potencies around 100 nM. However, in contrast to known pore blockers, NS8593 did not inhibit super(125)I-apamin binding. Using excised patches, it was demonstrated that NS8593 decreased the Ca super(2+) sensitivity by shifting the activation curve for Ca super(2+) to the right, only slightly affecting the maximal Ca super(2+)-activated SK current. NS8593 inhibited all the SK1-3 subtypes Ca super(2+)-dependently (K sub(d) = 0.42, 0.60, and 0.73 mu M, respectively, at 0.5 mu M Ca super(2+)), whereas the compound did not affect the Ca super(2+)-activated K super(+) channels of intermediate and large conductance (hIK and hBK channels, respectively). The site of action was accessible from both sides of the membrane, and the NS8593-mediated inhibition was prevented in the presence of a high concentration of the positive modulator NS309. NS8593 was further tested on mouse CA1 neurons in hippocampal slices and shown to inhibit the apaminand tubocurarine-sensitive SK-mediated afterhyperpolarizing current, at a concentration of 3 mu M.</abstract></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2006-11, Vol.70 (5), p.1771-1782
issn 0026-895X
language eng
recordid cdi_proquest_miscellaneous_19359957
source EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
title Inhibitory Gating Modulation of Small Conductance Ca super(2+)-Activated K super(+) Channels by the Synthetic Compound (R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) Reduces Afterhyperpolarizing Current in Hippocampal CA1 Neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20Gating%20Modulation%20of%20Small%20Conductance%20Ca%20super(2+)-Activated%20K%20super(+)%20Channels%20by%20the%20Synthetic%20Compound%20(R)-N-(Benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine%20(NS8593)%20Reduces%20Afterhyperpolarizing%20Current%20in%20Hippocampal%20CA1%20Neurons&rft.jtitle=Molecular%20pharmacology&rft.au=Stroebaek,%20Dorte&rft.date=2006-11-01&rft.volume=70&rft.issue=5&rft.spage=1771&rft.epage=1782&rft.pages=1771-1782&rft.issn=0026-895X&rft_id=info:doi/&rft_dat=%3Cproquest%3E19359957%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19359957&rft_id=info:pmid/&rfr_iscdi=true